Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04113343 · ClinicalTrials.gov registry record · Phase 1
Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
A Phase 1 study of Safety Issues, sponsored by Paion UK.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT04113343 is a Phase 1 study of Safety Issues that has completed, run by Paion UK. The registered enrollment target is 21 participants, below the 118-participant average among 13 other Safety Issues trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04113343, a Phase 1 study of Safety Issues, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
A Phase 1 Study to Determine the Single-dose Pharmacodynamics, Pharmacokinetics, and Safety and Tolerability of Remimazolam Following Oral Administration With and Without Alcohol in Healthy Female Subjects
Conditions Studied
Interventions
- DRUG Remimazolam
- OTHER Alcohol
Study Locations (1)
Utah
- PRA Health Sciences (PRA) - Early Development Services - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2017-08-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04113343
The ClinicalTrials.gov registry entry for NCT04113343 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 13 other Safety Issues trials with a reported enrollment target (82% lower). The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Safety Issues appearing as the primary indexed condition, and to 2 interventions - of which Remimazolam is the first listed.
NCT04113343 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04113343 about?
NCT04113343 is a clinical study titled "Oral Remimazolam With and Without Alcohol in Healthy Female Subjects". A Phase 1 Study to Determine the Single-dose Pharmacodynamics, Pharmacokinetics, and Safety and Tolerability of Remimazolam Following Oral Administration With and Without Alcohol in Healthy Female Subjects
What is the current status of trial NCT04113343?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2017-05-30. Estimated completion is 2017-08-09.
What conditions does trial NCT04113343 study?
This clinical trial studies the following conditions: Safety Issues.
What interventions are being tested in trial NCT04113343?
The interventions under investigation include: Remimazolam (DRUG), Alcohol (OTHER).
Who is sponsoring clinical trial NCT04113343?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04113343 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety Issues
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
ACTIVE NOT RECRUITING · Phase 1
-
A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
ACTIVE NOT RECRUITING · Phase 1
-
A Phase 1 Study of EXT608 in Healthy Adults
COMPLETED · Phase 1
-
Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study
COMPLETED · Phase 1
-
Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.